Insider Trading June 30, 2026 05:27 PM

Saba Capital Trims Holdings in BlackRock ESG Capital Allocation Term Trust Amid June Sales

The investor reduced its stake by offloading 188,125 shares across two transactions in late June, with remaining holdings valued at current market prices.

By Avery Klein
Share
Twitter Reddit Facebook LinkedIn
ECAT

Saba Capital Management, L.P., a significant shareholder in BlackRock ESG Capital Allocation Term Trust (NASDAQ:ECAT), executed a series of sales totaling approximately $2.91 million in late June. The transactions, which brought the firm's indirect ownership down to 17,742,619 shares, highlight active portfolio management within the trust. The trust, known for its high dividend yield and strong financial health metrics, continues to trade around $15.72, reflecting ongoing market interest in fixed-income and ESG-focused investment vehicles.

Saba Capital Trims Holdings in BlackRock ESG Capital Allocation Term Trust Amid June Sales
ECAT
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Saba Capital Management reduced its stake in BlackRock ESG Capital Allocation Term Trust by selling 188,125 shares across two transactions in late June 2026.
  • The trust maintains a strong financial profile, evidenced by a 20.6% total return over the past year and a 20.62% dividend yield, positioning it as a high-yield fixed-income vehicle.
  • The sale activity occurs within a narrow price band of $15.37 to $15.542, indicating controlled execution and potential market sensitivity to ESG fund flows.

Saba Capital Management, L.P., a ten percent owner of BlackRock ESG Capital Allocation Term Trust (NASDAQ:ECAT), reported sales of the trust’s common stock totaling approximately $2,910,809. The transactions occurred over two separate dates in late June.

On June 26, 2026, Saba Capital Management disposed of 75,754 shares of common stock at a price of $15.37 per share. Following this transaction, the firm’s indirect ownership in the trust stood at 17,854,990 shares. The trust currently trades at $15.72 and boasts a dividend yield of 20.62%, with InvestingPro data showing the fund pays a significant dividend to shareholders. The trust has delivered a 20.6% total return over the past year, earning a "GREAT" financial health score from InvestingPro, which offers 4 additional exclusive tips for ECAT investors.

Further sales took place on June 29, 2026, when Saba Capital Management sold an additional 112,371 shares. These shares were sold at a price of $15.542 per share. After this transaction, Saba Capital Management held 17,742,619 shares of BlackRock ESG Capital Allocation Term Trust.

The reported sales were conducted within a price range of $15.37 to $15.542 per share.

The filing was made public on June 30, 2026, for transactions that occurred on June 26 and June 29, 2026.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

BlackRock ESG Capital Allocation Trust

Follow

Analyze ECAT

Included in our AI-picked strategies

·Review strategies

15.72▲+0.08(+0.51%)Closed·15:59:59·USD15.75▲+0.03(+0.19%)After Hours·16:43:381D1W6M1Y5YMaxCreated with Highcharts 11.4.814:0015:0016:0017:0018:0019:0015.6515.715.75Analyze ECATIs ECAT a bargain right now?The fastest way to find out is with our Fair Value calculator. We use a mix of 17 proven industry valuation models for maximum accuracy. Get the bottom line for ECAT plus thousands of other stocks and find your next hidden gem with massive upside.See Undervalued Stocks

Risks

  • The high dividend yield of 20.62% may face sustainability pressures if underlying asset performance declines, impacting investor returns in the fixed-income sector.
  • Market volatility in ESG-focused funds could affect the trust's valuation, given its reliance on specific sector allocations and macroeconomic conditions.
  • Regulatory or policy shifts regarding ESG reporting standards may influence investor sentiment and capital flows into similar trust structures.

More from Insider Trading

Westwood Holdings Director Byrne Offloads $246K in Shares Under Pre-Arranged Plan Jun 30, 2026 Remitly Director Joshua Hug Executes $764,400 Stock Sale Under Pre-Arranged Plan Jun 30, 2026 Teladoc Health President Kelly Bliss Executes $21,250 Stock Sale Under Pre-Arranged Plan Jun 30, 2026 Disc Medicine's Chief Legal Officer Executes $187,500 Stock Sale Under Pre-Arranged Plan Jun 30, 2026 Ionis Pharmaceuticals EVP Joseph Baroldi’s Spouse Executes Pre-Arranged Stock Sales and Acquisitions Jun 30, 2026